Literature DB >> 2317013

Increased thymocyte differentiation in myasthenia gravis: a dual-color immunofluorescence phenotypic analysis.

L Durelli1, U Massazza, G Poccardi, M F Ferrio, R Cavallo, G Maggi, C Casadio, M Di Summa, L Bergamini.   

Abstract

Thymocytes express multiple, different surface antigens according to their stage of maturation. Surface differentiation antigens have been studied with the technique of simultaneous dual-color, direct immunofluorescence in the thymuses of 20 patients with myasthenia gravis (MG) and 10 control subjects with cardiac diseases. Fluorescein isothiocyanate-conjugated and phycoerythrin-conjugated monoclonal antibodies were used to stain thymic cell suspensions. A significant decrease in the percentage of immature and common thymocyte phenotypes (CD1+,3+ and CD4+,8+) and a significant increase in the percentage of mature thymocyte phenotypes (CD1-,3+; CD4+,8-; and CD4-,8+) and of B cells (CD20+) were found in MG thymuses compared with controls. These data, indicating an increased availability of mature, fully immunocompetent T and B cells, indirectly suggest the occurrence of an active immune response in MG thymus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317013     DOI: 10.1002/ana.410270213

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  5 in total

1.  Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma.

Authors:  Y Fujii; M Hayakawa; K Nakahara
Journal:  J Neurol       Date:  1992-02       Impact factor: 4.849

2.  Galectin-1 is expressed by thymic epithelial cells in myasthenia gravis.

Authors:  C Hafer-Macko; M Pang; J J Seilhamer; L G Baum
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

3.  Circulating CD3+ CD4+ CD8+ T lymphocytes in multiple sclerosis.

Authors:  F E Munschauer; C Stewart; L Jacobs; S Kaba; Z Ghorishi; S J Greenberg; D Cookfair
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

4.  Actuarial analysis of the occurrence of remissions following thymectomy for myasthenia gravis in 400 patients.

Authors:  L Durelli; G Maggi; C Casadio; R Ferri; S Rendine; L Bergamini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-05       Impact factor: 10.154

5.  CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS.

Authors:  Merve Çebi; Hacer Durmus; Fikret Aysal; Berker Özkan; Gizem Engin Gül; Arman Çakar; Mehmet Hocaoglu; Metin Mercan; Sibel P Yentür; Melih Tütüncü; Vildan Yayla; Onur Akan; Öner Dogan; Yeşim Parman; Güher Saruhan-Direskeneli
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.